3 min read
The Centers for Medicare and Medicaid Services (CMS) intends to alter assignment of Healthcare Common Procedure Coding System (HCPCS) Level II codes for certain physician-administered 505(b)(2) drugs. At its core, CMS has stated its desire to...
Read More
9 min read
Desert Horse-Grant and Dr. Jennifer McCaney, Co-Executive Directors, UCLA Biodesign This female dynamic duo founded UCLA’s Biodesign program in 2019...
5 min read
Paul LaViolette Managing Partner & COO, SV Health Investors Forging where others are tentative to trod, SV Health Investors, in partnership with...
1 min read
The Medicare NGS NCD grants national coverage for somatic testing in patients with advanced cancer if the test has FDA-approval or -clearance as a...
2 min read
In Germany, the Federal Joint Committee (G-BA) recently amended its rules of assessment procedures to consider new therapies and products without...
1 min read
The Centers for Medicare and Medicaid Services’ (CMS) New Technology Add-On Payment (NTAP) program is a system enacted by Congress and implemented in...
2 min read
The Chinese government has implemented a series of efforts to improve access to novel oncology therapies, one example of this is the significant...
1 min read
In March, leaders from our health economics team, Tom Goss and Jordan Hinahara shared insights on health technology assessments in the US under the...
1 min read
As a result of the new European Union Medical Device Regulations (MDR), existing products (most legacy devices) that already had received CE Mark...
4 min read
We recently discussed the challenges and opportunities for diagnostic players amidst and post- the COVID-19 chaos in the context of China’s health...
